1. Home
  2. PROF vs PNNT Comparison

PROF vs PNNT Comparison

Compare PROF & PNNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$6.24

Market Cap

238.1M

Sector

Health Care

ML Signal

HOLD

Logo PennantPark Investment Corporation

PNNT

PennantPark Investment Corporation

HOLD

Current Price

$4.63

Market Cap

285.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PROF
PNNT
Founded
N/A
2007
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
238.1M
285.3M
IPO Year
2017
2007

Fundamental Metrics

Financial Performance
Metric
PROF
PNNT
Price
$6.24
$4.63
Analyst Decision
Strong Buy
Hold
Analyst Count
1
5
Target Price
$12.00
$5.85
AVG Volume (30 Days)
215.8K
761.5K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
21.24%
EPS Growth
25.89
N/A
EPS
1.41
N/A
Revenue
$16,098,000.00
N/A
Revenue This Year
$92.40
N/A
Revenue Next Year
$64.10
N/A
P/E Ratio
$4.45
$13.14
Revenue Growth
50.73
N/A
52 Week Low
$3.92
$4.29
52 Week High
$8.95
$7.53

Technical Indicators

Market Signals
Indicator
PROF
PNNT
Relative Strength Index (RSI) 51.08 47.39
Support Level $5.86 N/A
Resistance Level $7.02 $4.93
Average True Range (ATR) 0.50 0.13
MACD 0.06 0.04
Stochastic Oscillator 65.29 78.75

Price Performance

Historical Comparison
PROF
PNNT

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

About PNNT PennantPark Investment Corporation

Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.

Share on Social Networks: